Therapeutic Effects of Human Mesenchymal Stem Cells in a Mouse Model of Cerebellar Ataxia with Neuroinflammation.

Abstract

Cerebellar ataxias (CAs) are neurological diseases characterized by loss of muscle coordination that is a result of damage and inflammation to the cerebellum. Despite considerable efforts in basic and clinical research, most CAs are currently incurable. In this study, we evaluated the therapeutic potential of human mesenchymal stem cells (hMSCs) against CAs associated with neuroinflammation. We observed that hMSC treatment significantly inhibited the symptoms of ataxia in lipopolysaccharide (LPS)-induced inflammatory CA (ICA) mice, which were recently reported as a potential animal model of ICA, through the anti-inflammatory effect of hMSC-derived TNFα-stimulated gene-6 (TSG-6), the protection of Purkinje cells by inhibition of apoptosis, and the modulatory effect for microglial M2 polarization. Thus, our results suggest that hMSC treatment may be an effective therapeutic approach for preventing or improving ataxia symptoms.

• Authors: Youngpyo Nam, Dongyeong Yoon, Jungwan Hong, Min Sung Kim, Tae Yong Lee, Kyung Suk Kim, Ho-Won Lee, Kyoungho Suk, Sang Ryong Kim
• Journal: Journal of clinical medicine (J Clin Med) Vol. 9 Issue 11 (Nov 13 2020) ISSN: 2077-0383 [Print] Switzerland
• PMID: 33202913 (Publication Type: Journal Article)